Navigation Links
New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
Date:10/16/2007

MIAMI, Oct. 16 /PRNewswire/ -- Roger K. Khouri, M.D. a noted Plastic and Reconstructive Surgeon, is presently leading a team of surgeons in a clinical trial performing a minimally invasive breast reconstruction technique utilizing the Brava external expansion system and liposuctioned micro-fat grafts primarily on women who have had a mastectomy or lumpectomy, with or without radiation therapy.

Typically, breast reconstruction procedures involve major, "open" surgery that requires extensive recovery time. With this new minimally-invasive outpatient breast reconstruction technique, the chest wall is first expanded by using the Brava System and is followed by the re-injection of small micro- grafts that are harvested, through a liposuction procedure, from the patients own body (autologous grafts). These micro-fat grafts are most often harvested from the patient's thighs, buttocks and stomach. A key element to the success of this procedure, an average 90% graft survival rate, is the preparation of the recipient breast site with the expansion device (Brava) enabling greater volumes of fat to be transferred, and its post operative use to stabilize the graft ensuring its survival. Slowly, after undergoing a few procedures, the breasts are reconstructed. Following each treatment, patients are ambulatory and recovery time is minimal.

The study is actively recruiting the following types of participants: post lumpectomy patients, post mastectomy patients or those post breast biopsy, that were left with a filling defect, who do not have breast implants. Further information about the clinical trial and enrollment criteria may be found at http://www.clinicaltrials.gov/ct/show/NCT00466765?order=1

About Dr. Khouri

Roger K. Khouri, M.D., is a world renowned plastic and reconstructive surgeon practicing in Miami, FL and the inventor of the Brava System. Prior to co-founding Brava, LLC, Dr. Khouri held professional and fellowship positions at Brown, Harvard, New York and Washington Universities.

About Brava, LLC

Brava, LLC, founded in 1999, is a medical device manufacturer. Products include the Brava Breast Enhancement System. Brava, LLC headquarters are located at 14221 S.W. 142nd Street, Miami, FL 33186


'/>"/>
SOURCE Brava, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Non-Invasive Diagnostic Tests for Celiac Disease
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
7. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
11. New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , le 27 Avril 2016 ... a progressé de +5% sur le trimestre, soutenu ... de consommables  Croissance de +16% des ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; ... confocale laser, annonce aujourd,hui son chiffre d,affaires pour ...
(Date:4/27/2016)... April 27, 2016 Elekta today ... platform will be the focal point of seven scientific ... European Society for Radiotherapy & Oncology, taking place April ... a state-of-the-art radiotherapy system and a high-field MRI scanner ... see the patient,s anatomy in real time. The MR-linac ...
(Date:4/27/2016)... , April 27, 2016   Zillion ... digital health technology platform, which specializes in live ... into scalable digital products, Zillion enables companies to ... empower consumers to take control of their health. ... video conferencing – including one-to-one, group and webcast ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. ... of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death ... podcasted thereafter . Dr. Bernie Siegel, author of a plethora of essential ...
(Date:4/29/2016)... Southlake, Texas (PRWEB) , ... April 29, 2016 , ... ... and neck pain, is proud to announce one of their physicians has been invited ... Osteopathic Family Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. ...
(Date:4/29/2016)... ... ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent of skin ... More than 10,000 people are expected to die of melanoma this year. The risk increases ... of the most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, ... round of funding led by Eastside Partners, with participation from existing investor Martin ... customer base and accelerate its technology and product roadmap. , “Jvion ...
(Date:4/29/2016)... ... ... Nike Softball Camp at the College of Brockport in New York is ... 10-18. All facets of the game will be covered; hitting, fielding, base-running, and team ... the finest softball facilities in the region. The outstanding professional college staff complement and ...
Breaking Medicine News(10 mins):